VIOXX® (rofecoxib), a popular anti-inflammatory drug manufactured by Merck &Co. Inc., is used for the treatment of arthritis and pain, most commonly for the treatment of acute and chronic osteoarthritis, rheumatoid arthritis, relief of pain in adults and treatment of menstrual discomfort.

Weitz & Luxenberg is the law firm that won the second major Vioxx lawsuit against Merck for a Vioxx heart attack victim in Atlantic City, a jury verdict of $13.5 Million. If you or a loved one has experienced a serious injury such as a heart attack or stroke after taking Vioxx, fill out this simple form for a FREE case evaluation from a Weitz and Luxenberg lawyer.

Vioxx has been distributed to over 20 million American citizens and 105 million prescriptions have been written world-wide.

In 2003, sales for Vioxx totaled 2.5 billion dollars.
On September 30th, 2004, Merck recalled Vioxx from the market after studies showed an increased risk of heart attacks, strokes, and other cardiovascular events in patients who had taken it, especially for longer than 18 months.

Regardless of the consequences Vioxx may have posed for patients taking this drug, Merck continued to promote Vioxx with a gross marketing budget of $500 million.

October 6th, 2004, the Wall Street Journal reported the drug may have been the cause of 27,000 heart attacks and sudden cardiac deaths before it was removed from the market.

People who have suffered injuries such as heart attacks and strokes after taking Vioxx for a prolonged period of time have filed suit on the grounds that Merck failed to fully reveal the dangerous side effects of the drug.

Individuals who have suffered a heart attack, stroke, or other cardiovascular event after taking Vioxx, and families who have suffered a loss after a loved one has taken the drug may be eligible to file a claim against Merck & Co. Inc.

http://www.weitzlux.com/vioxx/lawyer_20.html